Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-18

FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

The FDA approved Labetalol Hydrochloride as a generic drug under an Original Application by Advagen Pharma Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

ORIG AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)